Harold J. Burstein
- Oncology top 0.05%
- Cancer Research top 0.05%
- Pulmonary and Respiratory Medicine top 0.2%
- Molecular Biology top 2%
- Radiology, Nuclear Medicine and Imaging top 0.2%
- Co-authors
- Eric P. WinerJane C. WeeksClifford A. HudisJennifer J. GriggsHope S. RugoAntonio C. WolffRebecca GelmanAnn H. Partridge
- Topics
- Breast Cancer Treatment Studies (102 papers)HER2/EGFR in Cancer Research (84 papers)Cancer Treatment and Pharmacology (81 papers)
- Journals
- New England Journal of MedicineThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- United StatesItalySpain
In The Last Decade
Harold J. Burstein
214 papers receiving 18.6k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Oncology 11.9k
- Cancer Research 7.1k
- Pulmonary and Respiratory Medicine 4.4k
- Molecular Biology 2.8k
- Radiology, Nuclear Medicine and Imaging 2.8k
Countries citing papers authored by Harold J. Burstein
This map shows the geographic impact of Harold J. Burstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold J. Burstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold J. Burstein more than expected).
Fields of papers citing papers by Harold J. Burstein
This network shows the impact of papers produced by Harold J. Burstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold J. Burstein. The network helps show where Harold J. Burstein may publish in the future.
Co-authorship network of co-authors of Harold J. Burstein
This figure shows the co-authorship network connecting the top 25 collaborators of Harold J. Burstein. A scholar is included among the top collaborators of Harold J. Burstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold J. Burstein. Harold J. Burstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 20 | |
| 4 | 8 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 52 | |
| 8 | 5 | |
| 9 | 6 | |
| 10 | Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Updatebreakdown → | 411 |
| 11 | 15 | |
| 12 | 60 | |
| 13 | 15 | |
| 14 | 11 | |
| 15 | 446 | |
| 16 | Updates in anti-HER2 combination therapy. | 2 |
| 17 | 105 | |
| 18 | 150 | |
| 19 | Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomabreakdown → | 554 |
| 20 | 221 |
About Harold J. Burstein
Harold J. Burstein is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 220 papers that have together received 19.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (102 papers), HER2/EGFR in Cancer Research (84 papers) and Cancer Treatment and Pharmacology (81 papers). The work is most often cited by research in Cancer Research (7.1k citations), Oncology (11.9k citations) and Pathology and Forensic Medicine (2.6k citations). Harold J. Burstein has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Eric P. Winer, Jane C. Weeks, Clifford A. Hudis, Jennifer J. Griggs, Hope S. Rugo, Antonio C. Wolff, Rebecca Gelman, Ann H. Partridge, Stephen B. Edge and Mark R. Somerfield. Their work appears in journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.